Kinnari Patel, Chief Operating Officer at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 33,522 shares at $56.51 ($1.9M) on 2020-12-28, disclosed to the SEC on 2020-12-30.
Open-market sale of $1.9M RCKT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.51 | 11,334 | $640K | 33.7% |
| 2 | $56.51 | 11,334 | $640K | 33.7% |
| 3 | $57.17 | 5,427 | $310K | 16.3% |
| 4 | $57.17 | 5,427 | $310K | 16.3% |
| Total | $56.72 avg | 33,522 | $1.9M | 100% |
| Filing → |
| RCKT | BUY | 2025-04-10 | $198K | — | Filing → |
| RCKT | SELL | 2025-02-25 | $129K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |